Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program
Bibliographic Data
| ID | 11029210 |
|---|---|
| Authors | Holly Hagan (0000-0002-9020-9232, Public Health – Seattle & King County), D C Jarlais, Des Jarlais, R Friedman (0000-0003-2083-1226, Public Health – Seattle & King County), S R Friedman, David Purchase (Public Health – Seattle & King County), M J Alter (Public Health – Seattle & King County) |
| Year | 1995 |
| Volume | 85 |
| Issue | 11 |
| Pages | 1531-1537 |
| Publication date | 1995-11-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | American Journal of Public Health (JOURNAL) |
| Journal identifiers | ISSN: 0090-0036 • E-ISSN: 1541-0048 |
| Publisher | American Public Health Association (PUBLISHER • US) |
| DOI | 10.2105/ajph.85.11.1531 |
| PMID | 7485666 |
| OpenAlex | W2046844674 |
| Language | EN |
| Citations received | 45 |
| References cited | 28 |
OBJECTIVES. This case-control study examined the association between syringe exchange use and hepatitis B and C in injection drug users. METHODS. Case patients included 28 injection drug users with acute hepatitis B and 20 with acute hepatitis C reported to the health department in a sentinel hepatitis surveillance county; control subjects were injection drug users with no markers of exposure to hepatitis B or C (n = 38 and 26, respectively) attending health department services during the same period. Data were abstracted from clinic records. RESULTS. Seventy-five percent of case patients with hepatitis B and 26% of control subjects had never used the exchange; similar proportions were found for the hepatitis C case and control groups. After adjustment for demographic characteristics and duration of injecting drugs, nonuse of the exchange was associated with a sixfold greater risk of hepatitis B (odds ratio [OR] = 5.5; 95% confidence interval [CI] = 1.5, 20.4) and a sevenfold greater risk of hepatitis C (OR = 7.3; 95% CI = 1.6, 32.8). CONCLUSIONS. The results suggest that use of the exchange led to a significant reduction in hepatitis B and hepatitis C in the county and may have also prevented a substantial proportion of human immunodeficiency virus infections in injection drug users
Confidence interval · Drug · Hepatitis · Hepatitis B · Hepatitis B virus · Hepatitis C · Odds ratio · Psychiatry · Syringe · Virus · Hepatitis B Virus Studies · Hepatitis C virus research · HIV, Drug Use, Sexual Risk · Immunology · Internal Medicine · Medicine · Pharmacology · Virology
Impact Evaluation of a Policy Intervention for HIV Prevention in Washington, DC
Risk-Taking Behaviors Among Injecting Drug Users Who Obtain Syringes From Pharmacies, Fixed Sites, and Mobile Van Needle Exchanges
Secondary Syringe Exchange Among Injection Drug Users
Injection Drug Use and the Hepatitis C Virus
Selection Effect of Needle Exchange in Anchorage, Alaska
Public Funding of US Syringe Exchange Programs
High Rates of HIV Infection among Injection Drug Users Participating in Needle Exchange Programs in Montreal
Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users
Effectiveness of needle-exchange programmes for prevention of HIV infection
Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs
Needle exchange is not enough
Do Needle Syringe Programs Reduce HIV Infection Among Injecting Drug Users
What Are the Impacts of Needle Exchange on Young Injectors
Decline in Self-Reported High-Risk Injection-Related Behaviors Among HIV-Seropositive Participants in the Baltimore Needle Exchange Program
Hepatitis B and C Infections among Homeless Adolescents
Harm Reduction Policy Support among Students at Two U.S. Universities
Greater Drug Injecting Risk for HIV, HBV, and HCV Infection in a City Where Syringe Exchange and Pharmacy Syringe Distribution are Illegal
Changes in injection risk behavior associated with participation in the seattle needle-exchange program
Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programs
Characteristics and utilization patterns of needle-exchange attendees in Chicago
Injection Drug Users’ Perspectives on Placing HIV Prevention and Other Clinical Services in Pharmacy Settings
Can We Protect Drug Users from Hepatitis C
Rapid Identification of HIV Among People Who Inject Drugs
Heroin, Homicide and Public Health
Harm reduction in prisons
Syringe availability as HIV prevention
Point Defiance
Interventions to prevent HIV and Hepatitis C in people who inject drugs
Missed opportunities
Barriers to use of Needle and Syringe Programmes in a high drug use area of Sydney, New South Wales
Better models for Aids prevention
Preventing transitions to injecting amongst young people
Risk practices and other characteristics of injecting drug users who obtain injecting equipment from pharmacies and personal networks
Effectiveness of sterile needle and syringe programmes
The impact of an HIV prevention intervention for injecting drug users in Svetlogorsk, Belarus
Injecting behaviour of injecting drug users at needle and syringe programmes and pharmacies in Australia
Learn Harm Reduction
Evaluation of the impact of Dublin's expanded harm reduction programme on prevalence of hepatitis C among short-term injecting drug users
Multilevel Community-Based Intervention to Increase Access to Sterile Syringes Among Injection Drug Users Through Pharmacy Sales in New York City
Annotation
Increased Access to Unrestricted Pharmacy Sales of Syringes in Seattle–King County, Washington
Hepatitis C Screening and Management Practices
Science, Ideology, and Needle Exchange Programs
Evaluating effectiveness of syringe exchange programmes
Impact of law enforcement on syringe exchange programs
| Unique citing works | 45 |
|---|---|
| Citations per year | 1,45 |
| Citation span | 1995 - 2026 (32) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 44 |